Aberdeen Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.61M | Buy |
483,963
+169,377
| +54% | +$1.61M | 0.01% | 712 |
|
|
2025
Q1 | $3.29M | Buy |
314,586
+288,783
| +1,119% | +$3.02M | 0.01% | 717 |
|
|
2024
Q4 | $608K | Buy |
+25,803
| New | +$608K | ﹤0.01% | 861 |
|
|
2024
Q3 | – | Sell |
-17,869
| Closed | -$631K | – | 930 |
|
|
2024
Q2 | $631K | Buy |
+17,869
| New | +$631K | ﹤0.01% | 847 |
|